LifeMD, Inc.

NASDAQ:LFMD

Medical - Pharmaceuticals

Healthcare
$1.70 -3.27%

-$0.16 today

Market cap
$82.17M
Beta
1.99
P/E (TTM)
-13.8
EPS (TTM)
-$0.34
52W Low $2.56High $15.84

Volume 0.80M

Average 1.04M

LFMD Net Income

Bottom-line profit, the starting point for calculating cash from operations.

LifeMD, Inc.NASDAQ: LFMD

Net Income · Q1 FY2026 · quarter ended Mar 2026

Net income turns negative

Q1 FY2026 net income was -$8.87M, compared with $1.92M a year earlier. Trailing-twelve-month net income was $507.37K.

Context

  • Net income amounted to 8.0% of revenue in FY2025, down 0.8 pp from a year earlier.
  • Net income increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net income reaches the consensus estimate from 5 analysts of -$26.7M (-270.9%) for the fiscal year ending Dec 2026, a slowdown from the +183.4% reported in FY2025.

Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$8.87M-156.8% QoQ
Last fiscal yearDec 2025
$15.62M+183.4% YoY
LTMMar 2026
$507.37K+105.0% YoY
Net Income past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-562.9%+347.2%+910.2 pp
1 year+183.4%-270.9%-454.3 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Income history

USD · from the cash flow

Latest · FY2025
15.62M USD
Year-over-year change
+183.4%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Income vs competitors

How LFMD compares with its peers on the latest reported figures

  • Peers report in different currencies, so net income is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +105.0% is the 3rd highest of 10, against a peer median of +17.8%.
  • Net income amounts to 0.2% of revenue for LFMD, versus a peer median of 41.1%.
LFMD Competitors
Net Income for LFMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SENSSenseonics Holdings, Inc.LTM Mar 2026$87.19M USD+17.8%—214.2%
CVRXCVRx, Inc.LTM Mar 2026$52.66M USD+2.2%+8.8%89.1%
HITIHigh Tide Inc.LTM Apr 2026CA$46.43M CAD+388.6%-10.1%6.9%
SGHTSight Sciences, Inc.LTM Mar 2026$37.25M USD-24.6%-23.6%46.8%
MASS908 Devices Inc.LTM Mar 2026$35.6M USD+101.3%—61.6%
SMTISanara MedTech Inc.LTM Mar 2026$23.67M USD+103.8%+50.6%22.0%
TKNOAlpha Teknova, Inc.LTM Mar 2026$17.17M USD-26.3%-28.6%41.1%
TBRGTruBridge, Inc.LTM Mar 2026$16.51M USD+191.1%-35.0%4.8%
CERSCerus CorporationLTM Mar 2026$9.56M USD-49.7%-28.5%4.3%
LFMDLifeMD, Inc.LTM Mar 2026$507.37K USD+105.0%—0.2%
Peer median (excluding LFMD) —+17.8%-23.6%41.1%

Competitors are the stored peer set for LFMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(61.32M)(45.02M)(20.6M)(18.73M)15.62M
Depreciation & Amortization868.76K3.77M6.6M9.49M328.37K
Deferred Income Tax0354K000
Stock-Based Compensation12.07M13.73M12.49M12.23M10.5M
Change in Working Capital9.13M(1.55M)4.91M12.65M(7.85M)
Accounts Receivables17.7K(2.19M)(2.44M)(2.94M)1.15M
Inventory(409.82K)(2.18M)764.33K675.67K303.24K
Accounts Payables(893.96K)1.25M978.06K4.92M3.24M
Other Working Capital10.42M1.58M5.61M9.99M(12.55M)
Other Non-Cash Items6.17M5.78M5.42M1.87M(10.31M)
Operating Cash Flow(33.09M)(22.94M)8.82M17.51M8.28M
Capital Expenditures(3.4M)(12.89M)(8.73M)(11.54M)(9.52M)
Acquisitions (Net)0(1.01M)000
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(3.15M)(12.53M)(8.53M)(10.05M)8.78M
Investing Cash Flow(3.4M)(13.91M)(8.73M)(11.54M)6.91M
Debt Repayment(530.82K)2.74M16.67M(327.6K)(18.72M)
Common Stock Issued13.99M016.2M09.19M
Common Stock Repurchased00000
Dividends Paid(871.48K)(3.11M)(3.11M)(3.11M)(3.11M)
Other Financing Activities707.36K(159.2K)(667.63K)(684.83K)(773.66K)
Financing Cash Flow68.64M(528.2K)29.1M(4.12M)(13.41M)
Effect of Forex Changes00000
Net Change in Cash32.15M(37.37M)29.19M1.86M1.78M
Free Cash Flow(36.49M)(35.83M)86.95K5.98M(1.24M)

LifeMD, Inc.

NASDAQ:LFMD

Intrinsic Alpha fair value

Locked

Current Price

$1.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.